Alembic Dexaflox (10ml) is a prescription-strength, dual-action veterinary ophthalmic solution formulated to treat acute superficial bacterial eye infections accompanied by severe localized inflammation, swelling, and immune-mediated reactions in dogs and cats. The advanced therapeutic formula combines a potent fourth-generation fluoroquinolone antibiotic with a highly efficacious corticosteroid: Moxifloxacin Hydrochloride (0.5% w/v) and Dexamethasone Sodium Phosphate (0.1% w/v), sterilely prepared in an aqueous buffered vehicle.

Each active pharmaceutical ingredient targets a distinct component of ocular pathology. Moxifloxacin provides rapid, broad-spectrum bactericidal action against a wide array of Gram-positive and Gram-negative pathogens, effectively blocking essential bacterial enzymes (DNA gyrase and topoisomerase IV) required for bacterial DNA replication. Dexamethasone acts as a potent glucocorticoid that suppresses the inflammatory cascade at the cellular level, drastically reducing blood vessel dilation, tissue edema (swelling), capillary permeability, and the agonizing itching or burning sensations that cause pets to rub their eyes. In companion animal medicine, Dexaflox is highly effective for clinical management of severe bacterial conjunctivitis (pink eye), anterior uveitis, blepharitis, and post-operative inflammation following major ocular surgeries (such as cataract extractions).

Critical Safety Contraindication: Corticosteroid-containing ophthalmic drops like Dexaflox are strictly contraindicated in cases of active, deep, or melting corneal ulcers, as well as viral or fungal eye infections. Dexamethasone suppresses the local immune response and slows down cell regeneration, which can cause a simple corneal scratch to rapidly deteriorate into a catastrophic corneal perforation (rupture of the eye). A veterinarian must always perform a fluorescein stain test to verify that the corneal epithelium is 100% intact before this medication is introduced.